Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04463914 · ClinicalTrials.gov registry record · NA
Evaluation of a Mobile Therapy for Elevated Depressive Symptoms
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 649
- Enrollment target
NCT04463914: Completed NA study, sponsored by Medical University of South Carolina.
NCT04463914 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 649 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (54% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04463914, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 649 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate a mobile application (app) for depression treatment. Participants will be randomly assigned to either receive the mobile app, "Moodivate", or not. If provided with Moodivate, participants will be asked to use the app regularly, at least once per day, throughout the study duration. Participants will be asked to complete electronic questionnaire measures throughout the study period. Participation in this study will take about 12 weeks.
Primary Outcome
Patients will self report depressive symptoms weekly for 8 weeks with final follow-up at 12-weeks via the Beck Depression Inventory-II. The range of scores possible are 0 - 63, where lower scores are indicative of lower symptoms of depression.
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL Behavioral Activation Therapy app
- BEHAVIORAL Behavioral Activation Therapy app + EHR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 649 participants |
| Start Date | 2021-10-12 |
| Est. Completion | 2024-03-29 |
| Phase | NA |
What the finished NCT04463914 record still lists
NCT04463914 is an interventional study that assigns participants to a tested intervention. The registered 649 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (54% lower).
The record links to 0 conditions, and to 3 interventions - of which Treatment as Usual is the first listed.
NCT04463914 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04463914 about?
NCT04463914 is a clinical study titled "Evaluation of a Mobile Therapy for Elevated Depressive Symptoms". The purpose of this research study is to evaluate a mobile application (app) for depression treatment. Participants will be randomly assigned to either receive the mobile app, "Moodivate", or not. If provided with Moodivate, participants will be asked to use the app regularly, at least once per day,...
What is the current status of trial NCT04463914?
This trial is currently completed. It is a NA study. The enrollment target is 649 participants. The study started on 2021-10-12. Estimated completion is 2024-03-29.
What interventions are being tested in trial NCT04463914?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Behavioral Activation Therapy app (BEHAVIORAL), Behavioral Activation Therapy app + EHR (BEHAVIORAL).
Who is sponsoring clinical trial NCT04463914?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04463914's enrollment target sits among peer trials
649 156th of 2000 higher than 1,845 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02934477 · 650 participants
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- NCT04579120 · 650 participants
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- NCT04875702 · 650 participants · Phase 4
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
- NCT05046600 · 650 participants
Registry of Arthrex Hand and Wrist Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI